PAB
Click for more information
0.00% 0.8¢ patrys limited

Ann: Appendix 4E and 2023 Annual Report, page-19

  1. redant
    3,122 Posts.
    lightbulb Created with Sketch. 243
    clock Created with Sketch.
    23/09/23
    07:15
    Post #: 69988818
    "other company are building up their skills in the area of glioblastoma"
    Other companies do seem to be working on ADC's for breast cancer. Not sure about glioblastoma or if any have yet been able to cross the brain blood barrier. Link to article below -
    AstraZeneca, Daiichi hit first goal in breast cancer ADC trial (fiercebiotech.com)
    PAB Price at posting: 0.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $16.45M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
3 330704 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 5312414 5
View Market Depth
Last trade - 16.12pm 03/07/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.